| Identification | Back Directory | [Name]
[5-(4-chlorophenyl)-3-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-(furan-2-yl)methanone | [CAS]
489413-54-9 | [Synonyms]
WAY-272160
[5-(4-chlorophenyl)-3-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-(furan-2-yl)methanone
Methanone, [3-(4-chlorophenyl)-5-(2-furanyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-furanyl-
(3-(4-Chlorophenyl)-5-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)(furan-2-yl)methanone | [Molecular Formula]
C18H13ClN2O3 | [MOL File]
489413-54-9.mol | [Molecular Weight]
340.76 |
| Hazard Information | Back Directory | [Uses]
Topoisomerase I/II inhibitor 7 (Compound 5h) is a Topoisomerase I/II inhibitor[1]. | [IC 50]
Topoisomerase I; Topoisomerase II | [References]
[1] Ahmad P, et al. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure–activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor[J]. Bioorganic & Medicinal Chemistry, 2016, 24(8): 1898-1908. DOI:10.1016/j.bmc.2016.03.017 |
|
| Company Name: |
PHARMEKS Ltd.
|
| Tel: |
+7 (495) 702-9648 |
| Website: |
www.pharmeks.com |
|